Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: A bold FMRI study

NeuroImage

Volumn 78, Issue , 2013, Pages 176-185

  Lukas, Scott E ^a,b   Lowen, Steven B ^a,b   Lindsey, Kimberly P ^a,b   Conn, Nina ^a   Tartarini, Wendy ^a   Rodolico, John ^a,b   Mallya, Gopi ^a,b   Palmer, Christopher ^a,b   Penetar, David M ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alcoholism; Craving; FMRI; Magnetic resonance imaging; Naltrexone

Indexed keywords

MICROSPHERE; NALTREXONE; PLACEBO;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; BOLD SIGNAL; BRAIN FUNCTION; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DETOXIFICATION; DOUBLE BLIND PROCEDURE; EMOTION; EXTENDED DRUG RELEASE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFERIOR FRONTAL GYRUS; LEARNING; MALE; MEMORY; MIDDLE FRONTAL GYRUS; ORBITAL CORTEX; PRIORITY JOURNAL; PUNISHMENT; REWARD; SINGLE DRUG DOSE; SMELLING; VISUAL STIMULATION;

ADULT; ALCOHOLISM; BRAIN; BRAIN MAPPING; CUES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; VOLUNTEERS;

EID: 84877058838     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.03.055     Document Type: Article

References (56)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, (Washington, DC). fourth edition - (DSM-IV).
2. Anton R.F. What is craving? Models and implications for treatment. Alcohol Res. Health 1999, 23:65-173.
3. Anton R.F. Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale. Addiction 2000, 95(Suppl. 2):S211-S217.
4. Anton R.F., Drobes D.J., George M.S. Use of functional MRI to evaluate brain activity during alcohol cue exposure in alcoholics: relationship to craving. Alcohol. Clin. Exp. Res. 2001, 25(Suppl. 5):107S-108S.
5. Benjamin D., Grant E.R., Pohorecky L.A. Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res. 1993, 621:137-140.
6. Bouza C., Angeles M., Munoz A., Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004, 99:811-828.
7. Braus D.F., Wrase J., Grusser S., Hermann D., Ruf M., Flor H., Mann K., Heinz A. Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics. J. Neural Transm. 2001, 108:887-894.
8. Carlezon W.A., Thomas M.J. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 2009, 56(Suppl. 1):122-132.
9. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., O'Brien C.P. Limbic activation during cue-induced cocaine craving. Am. J. Psychiatry 1999, 156:11-18.
10. Ciraulo D.A., Qunming D., Silverman B.L., Gastfriend D.R., Pettinati H.M. Early treatment response in alcohol dependence with extended-release naltrexone. J. Clin. Psychiatry 2008, 6:190-195.
11. Cooney N.L., Litt M.D., Morse P.A., Bauer L.O., Gaupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated slcohol men. J. Abnorm. Psychol. 1997, 106:243-250.
12. Drobes D.J., Anton R.F., Thomas S.E., Voronin K. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcohol. Clin. Exp. Res. 2004, 28:1362-1370.
13. Drummond D.C. Theories of drug craving, ancient and modern. Addiction 2001, 96:33-46.
14. Garland E.L., Franken I.H., Howard M.O. Cue-reactivity heart rate variability and attentional bias predict alcohol relapse following treatment. Psychopharmacology 2012, 222:17-26.
15. Gastfriend D.R. Intramuscular extended-release naltrexone: current evidence. Ann. N. Y. Acad. Sci. 2011, 1216:144-166.
16. George M.S., Anton R.F., Bloomer C., Teneback C., Drobes D.J., Lorberbaum J.P., Nahas Z., Vincent D.J. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch. Gen. Psychiatry 2001, 58:345-352.
17. Gianoulakis C., Krishnan B., Thavundayil J. Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch. Gen. Psychiatry 1996, 53:250-257.
18. Grusser S.M., Wrase J., Klein S., Hermann D., Smolka M.N., Rug M., Weber-Fahr W., Flor H., Mann K., Braus D.F., Heinz A. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology 2004, 175:296-302.
19. Heinz A., Löber S., Georgi A., Wrase J., Hermann D., Rey E.-R., Wellek S., Mann K. Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alcohol Alcohol. 2002, 38:35-39.
20. Hommer D.W. Functional imaging of craving. Alcohol Res. Health 1999, 23:187-196.
21. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
22. Kareken D.A., Claus E.D., Sabri M., Dzemidzic M., Kosobud A.E.K., Radnovich A.J., Hector D., Ramchandani V.A., O'Connor S.J., Lowe M., Li T.K. Alcohol-related olfactory cues activate the nucleus accumbens and ventral tegmental area in high-risk drinkers: preliminary findings. Alcohol. Clin. Exp. Res. 2004, 28:550-557.
23. Kelley A.E. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004, 44:161-179.
24. Koob G.F. Animal models of craving for ethanol. Addiction 2000, 95(Suppl. 2):S73-S81.
25. Koob G., Nestler E. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 1997, 9:482-497.
26. Kranzler H.R. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcohol. 2000, 35:537-547.
27. Lorig T.S. EEG and ERP studies of low-level odor exposure in normal subjects. Toxicol. Ind. Health 1994, 10:579-586.
28. Lowen S.B., Lukas S.E. A low-cost, MR-compatible olfactometer. Behav. Res. Meth. 2006, 8:307-313.
29. Lukas S.E., Mendelson J.H. Electroencephalographic activity and plasma ACTH during ethanol-induced euphoria. Biol. Psychiatry 1988, 23:141-148.
30. Lukas S.E., Mendelson J.H., Benedikt R.A., Jones B. EEG alpha activity increases during transient episodes of ethanol-induced euphoria. Pharmacol. Biochem. Behav. 1986, 25:889-895.
31. Lukas S.E., Mendelson J.H., Benedikt R.A., Jones B. Instrumental analysis of ethanol-induced intoxication in human males. Psychopharmacology 1986, 89:8-13.
32. Lukas S.E., Mendelson J.H., Woods B.T., Mello N.K., Teoh S.K. Topographic distribution of EEG alpha activity during ethanol-induced intoxication in women. J. Stud. Alcohol 1989, 50:176-185.
33. Lukas S.E., Mendelson J.H., Kouri E.M., Bolduc M., Amass L. Ethanol-induced alterations in EEG alpha activity and apparent source of the auditory P300 evoked response potential. Alcohol 1990, 7:471-477.
34. Madsen K.H., Lund T.E. Filtering fMRI data by unsupervised modeling of physiological noise artifacts. 12th Annual Meeting of the Organization for Human Brain Mapping 2006, The Organization for Human Brain Mapping, Minneapolis.
35. McCaul M.E., Wand G.S., Eissenberg T., Rohde C.A., Cheskin L.J. Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology 2000, 22:480-492.
36. AHFS Drug Information. Naltrexone Hydrochloride 1999, 1839-1846. American Society of Health-System Pharmacists. G.K. McEvoy (Ed.).
37. McEvoy P.M., Stritzke W.G., French D.J., Lang A.R., Ketterman R. Comparison of three models of alcohol craving in young adults: a cross-validation. Addiction 2004, 99:482-497.
38. Monti P.M., Rohsenow D.J., Swift R.M., Gulliver S.B., Colby S.M., Mueller T.I., Brown R.A., Gordon A., Abrams D.B., Niaura R.S., Asher M.K. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol. Clin. Exp. Res. 2001, 25:1634-1647.
39. Myrick H., Anton R.F., Xingbao L., Henderson S., Randall P.K., Voronin K. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch. Gen. Psychiatry 2008, 65:466-475.
40. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch. Gen. Psychiatry 1992, 49:881-887.
41. O'Malley S.S., Garbutt J.C., Gastfriend D.R., Dong Q., Kranzler H.R. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. J. Clin. Psychopharmacol. 2007, 27:507-512.
42. Potgieter A.S., Deckers F., Geerlings P.A. Craving and relapse measurement in alcoholism. Alcohol Alcohol. 1999, 34:254-260.
43. Ray L.A., Hutchison K.E. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch. Gen. Psychiatry 2007, 64:1069-1077.
44. Rohan M., Killgore W., Eskesen J., Renshaw P., Yurgelun-Todd H.D. Match-warped EPI anatomic images and the amygdala: imaging in hard places. International Society for Magnetic Resonance and Medicine, 9th Scientific Meeting and Exhibition; and the European Society for Magnetic Resonance in Medicine and Biology 18th Annual Meeting and Exhibition; Glasgow, United Kingdom 2001.
45. Rohsenow D.J., Monti R.M. Does urge to drink predict relapse after treatment?. Alcohol Res. Health 1999, 23:225-232.
46. Saladin M.E., Gray K.M., Carpenter M.J., LaRowe S.D., DeSantis S.M., Upadhyaya H.P. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am. J. Addict. 2012, 21:210-220.
47. Sayette M.A., Shiffman S., Tiffany S.T., Niaura R.S., Martin C.S., Shadel W.G. The measurement of drug craving. Addiction 2000, 95(Suppl. 2):S189-S210.
48. Seo D., Jia Z., Lacadie C.M., Tsou K.A., Bergquist K., Sinha R. Sex differences in neural responses to stress and alcohol context cues. Hum. Brain Mapp. 2011, 32:1998-2013.
49. Sinclair J.D. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J. Clin. Psychopharmacol. 2001, 21:287-292.
50. Singleton E.G., Gorelick D.A. Mechanisms of alcohol craving and their clinical implications. Recent Dev. Alcohol 1998, 14:177-195. Plenum Press, New York.
51. Srisurapanont M., Jarusuraisin N. Opioid antagonists for alcohol dependence. Cochrane Database Syst. Rev. 2005, 25:CD001867.
52. Tiffany S.T. Cognitive concepts of craving. Alcohol Res. Health 1999, 23:215-224.
53. Tiffany S.T., Conklin C.A. A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction 2000, 95(Suppl. 2):S145-S153.
54. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 1992, 49:876-880.
55. Woolrich M.W., Ripley B.D., Brady M., Smith S.M. Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 2001, 14:1370-1386.
56. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 1992, 1-10. WHO, Geneva, Switzerland.